>





A 16-residue mitochondrial-derived peptide encoded within the 12S rRNA gene. Studied for AMPK activation and metabolic homeostasis.
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-residue peptide encoded within the mitochondrial genome and translated in the cytoplasm. It activates AMPK, modulates folate–methionine cycling, and is investigated for its roles in glucose homeostasis, exercise capacity, and longevity pathways.
Each vial is lyophilized from acetate buffer, sealed under nitrogen, and shipped cold-chain at −20 °C from our Kelowna facility.
AMPK-activation screens (Thr172 phosphorylation), 5-methyl-THF/SAM metabolomics, in-vitro glucose-uptake assays in skeletal myoblasts, and comparative mitochondrial-derived peptide pharmacology.
Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.
| Parameter | Value |
|---|---|
| Sequence | MRWQEMGYIFYPRKLR |
| Molecular formula | C₁₀₀H₁₅₈N₂₆O₂₂S |
| Molecular weight | 2174.55 g/mol |
| CAS number | 1627580-64-6 |
| Length | 16 residues |
| Test | Specification |
|---|---|
| HPLC purity | ≥ 99.0% (lot LM-2632: 99.13%) |
| Mass confirmation | ESI-MS within 0.5 Da |
| Net peptide content | ≥ 80% by AAA |
| Endotoxin | < 0.5 EU/mg (LAL) |
| Bioburden | < 10 CFU/g |
| Residual TFA | < 1.0% |
Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.
| Method | Result |
|---|---|
| RP-HPLC at 220 nm | 99.13% main peak |
| ESI-MS (positive) | 2174.6 Da (theor. 2174.55) |
| Amino acid analysis | 82.1% net peptide |
| LAL endotoxin | < 0.05 EU/mg |
| Karl Fischer (water) | 2.8% w/w |
Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.
Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.
Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.
Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab. 2015;21(3):443–454.
Reynolds JC et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
Kim KH et al. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression. Cell Metab. 2018;28(3):516–524.
MOTS-c reference standard, ≥99% (HPLC), Lumera Labs Inc., Cat. No. LUM-MOTSC-10, Lot 26-A031.
Mots C is a mitochondrial-derived peptide, classified within the mitochondrial-nuclear signaling pathway. Structurally it is a 16-residue MDP from MT-RNR1. MOTS-c is a 16-residue mitochondrial-derived peptide encoded within the 12S rRNA gene. Lee et al. (2015) demonstrated its role in metabolic homeostasis through AMPK activation.
In an in-vitro setting, Mots C interacts with its target receptor(s) at low-nanomolar affinities under standard binding-assay conditions. Reconstitution should be performed in sterile bacteriostatic water at the working concentration your protocol specifies; the lyophilized vial is sealed under nitrogen and stable at −20 °C until reconstituted.
Mots C arrives lyophilized at −20 °C in cold-chain insulated packaging. On receipt, transfer immediately to a −20 °C freezer. Once reconstituted, store at 2-8 °C and use within the window noted on the lot's COA. Avoid repeated freeze-thaw cycles.
For laboratory research only. Mots C is sold strictly as an in-vitro reference standard. It is not approved for human or veterinary use by Health Canada or the FDA.